Hourglass

Grapefruit USA, Inc. Comments on the recent NFL $1

LOS ANGELES and DESERT HOT SPRINGS, Calif., Feb. 08 2022 (GLOBE NEWSWIRE) — via InvestorWire — Grapefruit USA, Inc. (OTCQB: GPFT) (“Grapefruit” or the “Company”), a California-based innovation company based in Cannabiotech, comments on the recent award by the National Football League a million dollar research grant to study the use of cannabinoids to manage pain.

On February 1, 2022, the NFL awarded $1 million to two teams of medical researchers to study the effects of cannabinoids, including cannabis, on pain management and neuroprotection against concussions in NFL players. .

Researchers at the University of San Diego will study the effects of cannabinoids on pain from and recovery from sports-related injuries in NFL players. A second medical team from the University of Regina in Canada will study the use of naturally produced cannabinoids to manage pain and concussions, which regularly occur in contact sports such as organized football.

Bradley J. Yourist, CEO and Co-Founder of Grapefruit, commented, “The NFL’s $1 million research grant is a very forward-looking initiative by the league to advance the use of cannabinoids to manage pain and concussions. The NFL is wisely following Grapefruit’s efforts to study the effectiveness of cannabinoids in fighting sports pain and concussions. While we are pleased that these NFL initiatives validate Grapefruit’s efforts to research the use of cannabinoids to address sports-related pain and concussion issues, our customer experiences tell us that patented Hourglass THC products /CBD and CBD from Grapefruit provide our customers with the holistic benefits of cannabinoids without facing the dangers of smoking or eating cannabinoid products. It’s gratifying to see the NFL follow Grapefruit’s lead.

“Grapefruit’s Hourglass™ patented time-release THC/CBD and hemp-infused topical CBD creams align perfectly with the NFL’s cannabis initiative to find a way forward to introduce the holistic benefits of cannabis and herbal medicine. other cannabinoids in the NFL for the treatment of pain and the associated management of plans. We believe that if an elite NFL athlete had the choice of ingesting cannabinoids while smoking or using a topical cream, the choice would clearly be Hourglass™ Our Hourglass topical creams are the only cannabis products in the world that work at a high level without the need to expose their users to the health risks of smoking or the uncertainty of smoking. “oral ingestion of cannabis products. No one other than Pamplemousse or its authorized agents can manufacture, distribute or retail our line of hourglass topical creams,” Yo added. urist.

To purchase Grapefruit’s Revolutionary CBD Delivery Relief Cream outside of Canada, please visit: https://hourglassonlinestore.com/

To learn more about Grapefruit’s new Hourglass™ THC + Cannabinoid Sustained Release Topical Cream, please watch this promotional video: https://www.youtube.com/watch?v=6cU9MJMgH1w&feature=youtu.be
and visit our website at:
https://grapefruitblvd.com/hourglass/

For more investor information, please visit our website at:
https://grapefruitblvd.com/investor-relations/

Follow us on Facebook, Instagram, LinkedIn and Twitter:
Facebook | Instagram | LinkedIn | Twitter

About Grapefruit

Grapefruit is headquartered in Westwood, Los Angeles, California. Grapefruit holds California permits and licenses to manufacture and distribute cannabis products in the Golden State. The extraction laboratory and grapefruit manufacturing and distribution facilities are located in the industry-recognized Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park in Desert Hot Springs, located off North Canyon Road, approximately 14 miles north of downtown Palm Springs. For more information about Grapefruit and its business, please visit the company’s website at https://grapefruitblvd.com/.

Safe Harbor Statement

Grapefruit cautions that any statement included in this press release that is not a description of historical facts is a forward-looking statement. Many of these forward-looking statements contain the words “anticipate”, “believe”, “estimate”, “may”, “intend”, “expect” and similar expressions. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the Company’s expectations and are subject to a number of risks and uncertainties inherent in Grapefruit’s business, including, without limitation: the Company may never obtain the additional funds necessary to support its development and growth plans; and the Company may never achieve market success to achieve or maintain a profitable business. In addition, there are risks and uncertainties related to economic recession or terrorist actions, competition from much larger cannabis companies, unforeseen costs and delays, potential product liability claims and many other factors. More detailed information about grapefruit and risk factors that could affect the making of forward-looking statements is set forth in the company’s filings with the Securities and Exchange Commission, including the company’s Annual Report on Form 10- K, its Quarterly Report on Form 10-Q for the period ended September 30, 2021, and its registration statement on Form S-1/A. These documents can be read for free on the SEC’s website at www.sec.gov. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement, and Grapefruit undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof. This disclaimer is made pursuant to the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995.

Investor Relations:
Bradley Yourist
[email protected]
18776 Blue Dream Crossing, Unit LL1 53-07
Desert Hot Springs, California 92240
(760) 205-1382
https://grapefruitblvd.com/

Please note that our social media accounts may be used from time to time for additional material events. They can be found here:

Grapefruit USA:
Facebook: https://www.facebook.com/Grapefruit-Boulevard-2304698596251925/
Instagram: https://www.instagram.com/grapefruit_usa/
Twitter: https://twitter.com/grapefruitusa
LinkedIn: https://www.linkedin.com/company/grapefruit-boulevard/
Weed Maps: https://weedmaps.com/brands/grapefruit

Business communication :
InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]